VivoSim receives $5 million Lilly milestone
VivoSim Labs (NASDAQ:VIVS) received $5 million from Eli Lilly (NYSE:LLY) after first Phase 2 dosing and could earn another $45 million.

Crypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
VivoSim Labs (NASDAQ:VIVS) received $5 million from Eli Lilly (NYSE:LLY) after first Phase 2 dosing and could earn another $45 million.
Kaspi.kz (NASDAQ:KSPI) announced it completed the acquisition of Rabobank A.Ş. to expand its digital banking operations for its regional network of 25 million consumers.
Highway Holdings (NASDAQ:HIHO) reported fiscal 2026 revenue of $4.8 million and a shareholder-attributable net loss of $1.5 million, or $0.33 per share.
Kandi Technologies (NASDAQ:KNDI) began production at its Lin’an manufacturing base, which the company expects could produce up to 200 battery-swap stations annually.
ARK Invest increased its investment in Circle by buying about US$13.9 million in shares while reducing its position in Robinhood.
The U.S. Commodity Futures Trading Commission told Kalshi not to cancel completed Michigan trades despite a state court order.
Global Lithium Resources (ASX:GL1) executed an agreement to acquire the Nova Nickel-Copper-Cobalt Project from IGO (ASX:IGO).
VRX Silica (ASX:VRX) has executed strategic equity placements to major mining investment funds to raise $4.5 million.
Ripple has burned another 10 million Ripple USD (CRYPTO:RLUSD) tokens as part of its stablecoin supply management process.
Iris Metals (ASX:IR1) has commenced exploration at the Finley Basin Tungsten Project, planning 7,000m of diamond drilling.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy